Hyperuricemia aggravates the progression of IgA nephropathy.
Geng YH, Zhang Z, Zhang JJ, Huang B, Guo ZS, Wang XT, Zhang LQ, Quan SX, Hu RM, Liu YF.
Int Urol Nephrol. 2022 Sep;54(9):2227-2237. doi: 10.1007/s11255-022-03125-4. Epub 2022 Jan 24.
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy.
Hu H, Li W, Hao Y, Peng Z, Zou Z, Wei J, Zhou Y, Liang W, Cao Y.
Cell Rep Med. 2024 Aug 20;5(8):101690. doi: 10.1016/j.xcrm.2024.101690.
Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury.
Su HY, Yang C, Liang D, Liu HF.
Biomed Res Int. 2020 Jun 26;2020:5817348. doi: 10.1155/2020/5817348. eCollection 2020.
Vitamin C alleviates hyperuricemia nephropathy by reducing inflammation and fibrosis.
Li H, Liu X, Lee MH, Li H.
J Food Sci. 2021 Jul;86(7):3265-3276. doi: 10.1111/1750-3841.15803. Epub 2021 Jun 23.
Uric acid and cardiovascular risk.
Feig DI, Kang DH, Johnson RJ.
N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885.
Uric acid and the kidney.
Fathallah-Shaykh SA, Cramer MT.
Pediatr Nephrol. 2014 Jun;29(6):999-1008. doi: 10.1007/s00467-013-2549-x. Epub 2013 Jul 4.
Insights into renal damage in hyperuricemia: Focus on renal protection (Review).
Yang H, Ying J, Zu T, Meng XM, Jin J.
Mol Med Rep. 2025 Mar;31(3):59. doi: 10.3892/mmr.2024.13424. Epub 2024 Dec 24.
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
Kimura Y, Tsukui D, Kono H.
Int J Mol Sci. 2021 Nov 17;22(22):12394. doi: 10.3390/ijms222212394.
Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-beta/SMAD3 signaling.
Ren Q, Tao S, Guo F, Wang B, Yang L, Ma L, Fu P.
Phytomedicine. 2021 Jul;87:153552. doi: 10.1016/j.phymed.2021.153552. Epub 2021 Mar 22.
Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis.
Zhao H, Chen X, Zhang L, Meng F, Zhou L, Pang X, Lu Z, Lu Y.
Pharmacol Res. 2022 Aug;182:106350. doi: 10.1016/j.phrs.2022.106350. Epub 2022 Jul 14.
